Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2638_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
53 Мб
Скачать
Extremes of t emper ature  255
https://t.me/medicina_free
with increased incidence seen at the extremes of age, due to sub­optimal homeostatic thermoregulation. Peaks of incidence are com­mon during heatwaves, exemplied by the 70 000 heat-related deaths reported during the 2003 European heatwave. Conversely, exertional heat illness predominantly affects young, physically t individuals (such as soldiers and athletes), reecting a failure to dissipate intrinsic heat production from physical activity.
Risk factors for the development of heat illness are well established
(Box 12.6).
Pathophysiology of heat stroke
The pathophysiology of heat stroke can be summarised as organ dys­function from the high temperature itself, and end-organ ischaemia from diminished blood ow. Increased sweating results in dehydration and blood pools in vasodilated peripheral vasculature resulting in a decreased effective blood volume. The blood viscosity increases resulting in heart strain. Enzymes denature at 40 °C and at 41 °C mitochondrial activity stops; the subsequent loss of oxidative phosphorylation results in organ ischaemia. The muscles and gastrointestinal tract are affected rst, fol­lowed by the central nervous system, circulatory and clotting systems. The pathophysiology is similar to sepsis, severe trauma and extensive burns (Box 12.7).
Management
Mortality of heat illness is around 30% and is directly proportional to the duration and magnitude of hyperthermia, therefore immediate cooling should begin at the scene, before transfer to hospital. The aim should be to reduce core temperature to approximately 39°C.
A patient should be removed from the heat source and put into shade to reduce radiant heat gain. Resting in an air-conditioned room has cool­ing rates of 0.03–0.06°C/min. Clothes should be removed, high-ow oxygen administered, intravenous access established and a rectal tem­perature taken. If temperature measurement is unavailable but the history and clinical ndings are consistent with heat illness, initiation of treatment with cooling techniques should not be delayed.
A number of cooling strategies exist ( Box 12.8), and their implemen­tation will depend on what is feasible within each particular environment. Two meta-analyses have concluded that ice water immersion is the most effective treatment strategy with cooling rates of 0.20–0.35°C/min for iced water and 0.11°C/min for wet towels. Immersion is unlikely to be feasible in the wilderness environment and many hospitals, with fur­ther consideration of the potential dangers of immersing a patient with a reduced conscious level. Immersing the hands and forearms in cold water results in reduction of heat stress in normal subjects, but has not been evaluated in the treatment of heat stroke patients.
The placement of ice/cold packs in the axillae, groin and neck has been recommended as an easy method to use in the eld, but when compared with evaporative cooling in healthy subjects, cooling times were longest when the ice packs were used alone and shortest when both methods were used simultaneously. Evaporative cooling involves the removal of clothing, spraying tepid or cool water over the patient, and facilitating evaporation and convection with the use of a fan.
The role of invasive cooling methods such as gastric, bladder or peri­toneal lavage has not been fully established. Neither hyperhydration nor dantrolene (used in the treatment of malignant hyperthermia) have
12
12.6 Risk factors for the development of heat-related illness
Risk factor Mechanism
High ambient temperatures Increased radiant heat gain
High humidity Ineffective evaporative heat loss at
humidities > 75%
Little shade Increased radiant heat gain
Intercurrent illness Raised core temperature
Extremes of age Suboptimal homeostatic thermoregulation
Overweight/unt The main identiable risk factor for heat
Effects of alcohol and medication (diuretics, ACE inhibitors, β-adrenoceptor antagonists, vasodilators, antidepressants,
illness during military training was a body mass index (BMI) ≥ 30 kg/m
Either through dehydration, decreased cardiovascular and peripheral response to dissipate heat, reduced sweating or increased metabolic rate
2
anticholinergics, antihistamines and stimulants)
Inappropriate clothing Reduced heat loss through combination
of radiation, convection and evaporation
Dehydration Regardless of body habitus or tness
level, uid losses that result in a 2%–3% decrease in body weight correlate with decreased aerobic performance, increased perception of fatigue, and greater core temperatures at a given workload
Previous heat-related illness Impaired homeostatic thermoregulation
No acclimatisation Body uid decits are reduced by around
30% in acclimatised individuals, despite increased sweat rates of up to 18%, as a result of a more accurate thirst response
Intense work/duration Increased heat generation
12.7 Pathophysiology of heat stroke
Increased heart rate and an increase in cardiac output by 3 L/min for each 1°C rise in core temperature. Increased peripheral blood ow from
0.2 L/min up to 8 L/min. Dehydration with sweat rates increasing from 0.5 L/day up to 15 L/day. Risk of heart failure if pre-existing cardiac disease
Ischaemia and cerebral oedema due to the high temperature itself and vascular endothelial damage
Intestinal mucosal impairment results in toxins entering the portal vein and circulating systemically resulting in sepsis
Tachypnoea and pulmonary vasodilatation result in acute respiratory distress syndrome (ARDS) (p. 201)
Acute renal failure due to ischaemia, dehydration and rhabdomyolysis (p. 198)
Acute liver injury from ischaemia and high levels of circulating inammatory cytokines (p. 879)
Microthrombus formation causing further ischaemia and disseminated intravascular coagulation (p. 988)
2+
K
Mg
H
H
K
K
2+
Mg
Mg
Multiple electrolyte abnormalities including
H
hypokalaemia, hypomagnesaemia, hypoglycaemia and metabolic acidosis
2+
256  M EDI C IN E IN AU S TER E E N VIR O NM E NTS
https://t.me/medicina_free
12.8 Summary of cooling rates
Cooling technique (target < 39°C)
Cooling rate
Ice water immersion 0.20–0.35°C/min
Wet towels 0.11°C/min
Evaporative and convective
0.034–0.31°C/min
combined
Air-conditioned room 0.03–0.06°C/min
Intravenous cold saline 0.03°C/min
Intravenous room-temperature saline 0.015°C/min
12.9 Wet Bulb Globe Temperature (WBGT)
Meteorological conditions affect environmental temperatures and a widely used index to calculate this is the WBGT, originally developed by the US Marines. WBGT is an apparent temperature measurement taking into account temperature, humidity, wind speed and solar radiation. This gives a much more accurate representation of the degree of heat stress experienced. WBGT is used to formulate a set of guidelines that guide activity levels, hydration and rest periods. For example, a ‘do not start’ WBGT of 21°C has been suggested for American marathons based on an unsuccessful attempt of 160 per 1000 nishers above this level, although the incidence of heat-related illness is not well described.
evidence of benet. Cold intravenous uids may supplement cooling. In a study of healthy volunteers, infusion of 4°C saline over 30 minutes cooled the body by 1°C, compared to 0.5°C with room-temperature saline.
Highest
Pressurised
aircraft cabin
(< 2400 m)
22
20
18
16
14
12
10
Partial pressure of oxygen (kPa)
Partial pressure of inspired oxygen
8
6
4
0 2000 4000 6000 8000
Altitude above sea level (m)
permanent habitation (< 5200 m)
Arterial oxygen saturation
Summit of Everest (8848 m)
100
90
80
70
60
50
40
Arterial oxygen saturation (%)
Fig. 12.4 Change in inspired oxygen tension and blood oxygen saturation at
altitude. The blue curve shows changes in oxygen availability at altitude and the red curve shows the typical resultant changes in arterial oxygen saturation in a healthy person. Oxygen saturation varies between individuals according to the shape of the oxygen–haemoglobin dissociation curve and the ventilatory response to hypoxaemia. (To convert kPa to mmHg, multiply by 7.5.)
period of acclimatisation, the body is able to adapt and overcome even profound hypoxaemia with arterial partial pressures of oxygen ( PaO
2.55 kPa recorded at 8400 m in a healthy climber (normally > 10.6 kPa at sea level).
) of
2
Prevention
Cooling in a wilderness setting may be incredibly challenging, with likely no access to ice or cold uids. Prevention of heat illness is therefore paramount. Strategies include:
1. Ensuring adequate hydration. The 2019 Wilderness Medical Society heat illness guidelines identify hydration as the ‘most readily modi­able physiologic risk factor’. Fluid ingestion is also identied as the most effective approach to mitigate the rise in core temperature amongst athletes. Military guidelines recommend a 0.25–1.25 L/hr hydration strategy that varies for work rates (low/medium/high/very high) at a given Wet Bulb Globe Temperature (WBGT) (Box 12.9).
2. Consider accepted WBGT cut-offs for activities (Box 12.9).
3. Expedition participants should receive high-level education pre­departure on the dangers of heat-related illness with evidence­based advice on risk reduction. Increased hydration and cooling strategies have been documented following educational material targeting older people prior to heatwaves.
4. If possible, implementing a period of acclimatisation with at least 1–2 hours of mild exertion in a hot environment for at least 8 days. Body uid decits are reduced by around 30% in acclimatised individuals as a result of a more accurate thirst response.
Acute high altitude illness
Illness due to high altitudes represents over a quarter of all serious med­ical incidents from reviews of expeditions in a range of environments. High altitude is generally considered to be over 2500 m and extreme altitude over 5500 m. The summit of Mount Everest stands at 8848 m, where the barometric pressure and atmospheric partial pressure of oxy­gen (PO
gen remains the same at 20.9%.
utes if the body is exposed to an altitude over 8000 m. However, with a
) is around one-third of that at sea level; the percentage of oxy-
2
Unconsciousness secondary to hypoxia normally occurs within 3 min-
Physiological effects of high altitude
There are a number of physiological systems affected by altitude.
Respiratory
Reduction in oxygen tension results in a fall in arterial oxygen satura­tion (Fig. 12.4). This varies widely between individuals, depending on the shape of the sigmoid oxygen–haemoglobin dissociation curve (see
Fig. 25.5) and the ventilatory response. Alveolar ventilation increases
with altitude, lowering carbon dioxide and resulting in a respiratory alkalosis, with metabolic compensation via renal bicarbonate loss. At high altitude, individuals are at the steep section of the oxygen disso­ciation curve whereby a small fall in PaO
decrease in oxygen saturation. The initial respiratory alkalosis shifts the curve to the left but with a period of acclimatisation, increased produc­tion of 2,3-diphosphoglycerate moves the curve rightwards towards a sea-level position.
can result in a substantial
2
Haematological
Measured haemoglobin concentration increases with acclimatisation – a 20% fall in plasma volume causes haemoconcentration and erythro­poietin release (stimulated by hypoxia) leads to increased production of haemoglobin.
Cardiovascular
There is an initial increase in cardiac output due to increased sympathetic activity and heart rate. The reduction in plasma volume causes a fall in preload and stroke volume. Cardiac output returns to baseline over sev­eral weeks but the stroke volume remains lowered.
Illness at high altitude
Neurological and respiratory complications from high altitude occur in individuals who ascend rapidly and are not acclimatised. Acute mountain sickness (AMS) is seen in over a third of people who ascend to 3000 m. Serious illness includes high altitude pulmonary oedema (HAPE) and
Suba qu atic medic ine  257
https://t.me/medicina_free
high altitude cerebral oedema (HACE), occurring in 0.1–4% of people climbing over 4000 m. Prevention is essential and achievable through controlled ascents.
Acute mountain sickness
AMS is a syndrome comprised principally of non-specic symptoms including headache, fatigue, anorexia, nausea and vomiting, insomnia and dizziness. The pathophysiology of AMS is not fully understood but it is thought that hypoxia results in vasodilation and increased capil­lary hydrostatic pressure causing a uid leak and a raised intracranial venous volume with risk of raised intracranial pressure. There is believed to be an increase in CSF production with a reduced buffering capacity. Non-acclimatised individuals show impaired gas exchange and a lower degree of hyperventilation, alongside uid retention and a heightened sympathetic activation. Symptoms can occur within 4 hours, with the diagnostic denition specifying an ascent to > 2500 m within the prior 4 days. The symptoms can vary in severity, from trivial to completely incapacitating.
Management
Treatment of mild cases consists of rest and symptomatic control with simple analgesia; symptoms usually resolve after 1–3 days at a stable altitude, but may recur with further ascent. Occasionally there is progres­sion to cerebral oedema (HACE). Persistent symptoms indicate the need to descend, which is considered the denitive treatment.
Medication options include acetazolamide and dexamethasone. Acetazolamide is used in both the prophylaxis of AMS and as a treat­ment option. It works as a carbonic anhydrase inhibitor in the kidneys, increasing bicarbonate excretion and inducing a metabolic acidosis, thereby offsetting the hyperventilation-induced alkalosis seen at altitude. It also decreases CSF production, reducing intracranial pressure and risk of progression to HACE. Ideal dosing strategies are debated, however 125 mg twice daily may be used as prophylaxis and 250 mg three times daily for treatment. Higher doses (750 mg) have greater efcacy but also increased side-effects. Dexamethasone (8 mg) moderates capillary leak and reduces the inammatory response, improving symptoms to allow for a safe descent.
High altitude cerebral oedema
HACE is considered a severe sequela of AMS, presenting as ataxia or cognitive impairment in addition to the symptoms described above. It very rarely occurs without being preceded by milder AMS symptoms, making early recognition and treatment of AMS essential. Untreated HACE can progress to coma within 24 hours.
Management
Management is directed at improving oxygenation. Descent is essen­tial and dexamethasone (8 mg immediately, followed by 4 mg four times daily) should be given. If descent is impossible, descent can be simulated with the use of portable hyperbaric chambers, such as a Gamow bag. Use of these devices, however, can be difcult in patients with vomiting or a reduced level of consciousness.
High altitude pulmonary oedema
HAPE is a life-threatening condition that usually occurs in the rst 4 days after ascent above 2500 m and is the leading cause of mortality from high altitude illness. It is dened as an imbalance of hydrostatic pressure within the alveoli with no evidence of inammatory changes. Hypoxic pulmo­nary vasoconstriction causes alveolar capillary stress failure and subse­quent pulmonary hypertension. This results in capillary uid leak which is exacerbated by exercise and compounded by impaired epithelial sodium transport, normally essential for uid reabsorption. Initial symptoms include a dry cough, exertional dyspnoea and extreme fatigue. Later, the cough becomes wet with haemoptysis and orthopnoea. Tachycardia
and tachypnoea occur at rest and crepitations may often be heard in both lung elds. Fever may also be present. There may be profound hypoxaemia and radiological evidence of diffuse alveolar oedema. HAPE may occur without the preceding signs of AMS, although around 50% of patients with HAPE have concurrent AMS and 14% have HACE.
Management
Treatment is directed at reversal of hypoxia, with immediate descent (by a minimum of 1000 m) and oxygen administration targeting satura­tions > 90%. A portable hyperbaric chamber should be used if descent is delayed. Nifedipine (60 mg modied release divided into 2–3 doses) is recommended prophylactically, starting 1 day before attempting ascent above 2500 m and continued for a further 5 days at altitude or until descent below 2500 m. For treatment of HAPE there is no evidence of benet for any pharmacological therapy compared to descent and oxygen.
Subaquatic medicine
Drowning
Drowning remains a leading cause of death globally and is dened as ‘the process of experiencing respiratory impairment from submersion/ immersion in liquid’. Immersion refers to the upper airway being above the water surface and submersion below it. The drowning process involves initial breath holding, followed by a period of laryngospasm. Gas exchange is prevented resulting in hypoxia, hypercarbia and aci­dosis. Respiratory movements are stimulated by the respiratory centre due to hypercarbia, however the laryngospasm results in obstruction of the airway. The laryngospasm eventually falters with continued hypoxia resulting in the aspiration of liquid of a variable amount, usually < 4mL/kg.
Aspiration of either saltwater or freshwater results in changes to the alveolar surfactant and the alveolar capillary barrier causing atelectasis, ventilation–perfusion mismatch and hypoxia. Saltwater is hypertonic resulting in bronchoconstriction, inammation and pulmonary oedema; aspiration of 2.5 mL/kg of seawater results in a 75% increase in right­to-left shunting of deoxygenated blood. Fresh water is hypotonic and is generally absorbed through the pulmonary circulation, entering the sys­temic circulation and damaging the alveolar capillary membrane. This can also generate foam which further decreases ventilation efciency. The clinical signicance of swallowing water into the stomach during the drowning process remains unclear. Clinically signicant electrolyte abnor­malities from aspiration and swallowing of both hypotonic and hypertonic uids are uncommon requiring > 22 mL/kg of uid, although both hyper­and hyponatraemia have been described.
The majority of drownings occur in cold water that results in body cooling, water being considered thermoneutral at around 35°C. Skin cooling (cold shock) and tissue cooling (hypothermia) are important fac­tors in drowning. The historical term ‘dry-drowning’ refers to the 10% of drowning cases that are documented to have ‘macroscopically dry lungs’ on examination, attributed to laryngospasm from water irritation on contact. This remains controversial but is no longer felt to be true, with newer evidence demonstrating the presence of microscopic liquid in the lungs of all drowned patients. ‘Secondary drowning’, referring to patients who develop acute respiratory distress syndrome (ARDS), is now also considered a misnomer as there is no second submersion and ARDS is a recognised complication of the drowning process.
Cold shock
The cold shock response is believed to be responsible for the major­ity of drowning deaths. Sudden cold-water immersion results in an uncontrolled reex inspiratory gasping, hyperventilation with profound hypocapnia and tachycardia from activation of peripheral sub-epider­mal cold receptors. There is a 75% reduction in breath hold time, which can therefore result in the aspiration of water. The response is maximal
12
258  M EDI C IN E IN AU S TER E E N VIR O NM E NTS
https://t.me/medicina_free
at water temperatures of 10–15 °C and peaks within the rst 30 sec­onds of immersion, waning over 2–3 minutes. Continued immersion then results in physical incapacitation from neuromuscular cooling, with peripheral paralysis occurring at regional limb temperatures of 5–15 °C. Hypothermia develops after around 30 minutes in cold water.
Autonomic conict
Simultaneous positive and negative chronotropic triggers are considered arrhythmogenic. Bradycardia from vagal stimulation (initiated when face down in water – dive reex) coupled with a tachycardia from sympathetic activation (cold, stress or exercise) can generate arrhythmias in previ­ously healthy individuals and can be fatal in those with structural cardiac abnormalities.
Pre-hospital management
In-water CPR and rescue breaths are no longer recommended. In-water rescue is not recommended for untrained individuals – remember ‘Reach, Throw, Row, Don’t Go’. If extracting someone from the water following prolonged immersion, the patient should be kept horizontal to prevent post-immersion hypotension; the loss of hydrostatic pressure that the water was applying can result in venous pooling and a sudden circulatory collapse. The patient should be kept warm, with life support commenced at the earliest opportunity. Cervical spine precautions should be consid­ered as there may be a traumatic precursor to the drowning incident (e.g. tombstoning), although these injuries are uncommon (0.5% of cases). Postural drainage techniques to try to clear uid from the lungs have no proven benet.
In-hospital management
Treatment is often focused on re-warming and organ support including non-invasive ventilation (CPAP) and protective lung ventilation strategies for acute lung injury/ARDS. Prolonged immersion can result in hypovol­aemia due to the hydrostatic pressure effect of water and the patient may require IV uid. Prophylactic antibiotics are not recommended unless submersion was in grossly contaminated water. Asymptomatic patients, with no respiratory compromise, a normal chest X-ray and normal arterial blood gas can be discharged home after 6–8 hours’ observation.
A brief review of the physics and physiology of diving is essential in
understanding the medical issues encountered. The two most important gas laws are Boyle’s law and Henry’s law (Fig. 12.5).
Decompression sickness
Nitrogen bubble formation on ascent can cause direct mechanical damage to the vascular endothelium and an inammatory response. The bubbles occur almost anywhere in the body; therefore, the clinical presentation is broad ranging from malaise and headache to paraes­thesiae, lymphoedema, rash, joint pain and neurological manifestations including ataxia, paralysis and altered mentation. The overall incidence is low (0.03%) for recreational divers. Decompression sickness is very uncommon for diving depths less than 10 m and is normally seen follow­ing multiple dives.
A
Boyle’s law
Depth in
metres
0
10
20
30
40
Henry’s lawB
Pressure in
atmospheres
1
2
3
4
5
Volume of a
sealed container
1
1/2
1/3
1/4
1/5
6L
3L
2L
1.5L
1.2L
Lung
volume
CPR modications
Five initial rescue ventilations are recommended given the hypoxic nature of a cardiac arrest in drowning. The patient’s chest should be dried before application of debrillation pads; however less than 5% of drowned patients are in a shockable rhythm. The common progression of cardiac rhythm is from bradycardia, to pulseless electrical activity, to asystole. Submersion in ice-cold water (less than 6°C) may con­fer improved survival due to neuroprotection from rapid brain cooling before the onset of severe hypoxia; children in particular appear to have greater protection, believed in part to be due to a greater surface area to mass ratio allowing quicker cooling. For submersion times greater than 30 minutes in water warmer than 6°C, resuscitation is likely to be futile. If water temperature is below 6°C resuscitation is likely to be futile following a submersion over 90 minutes long. Submersion within a vehicle may prolong these times due to the potential presence of an air bubble. International guidelines do vary on the futility associated with submersion duration. The overall mortality of drowned patients who present in cardiac arrest is 93%.
Decompression illness
Changes in environmental pressure (as seen in diving) can result in decompression illness due to intravascular or extravascular bubbles, the clinical manifestations of which include both arterial gas embolism and decompression sickness. Diagnosis of decompression illness is based on the history and clinical features in patients following a dive; 90% of cases are symptomatic within 6 hours, however, delays up to 72 hours are described.
Surface
Compression
Decompression
Isopression
= Nitrogen
Fig. 12.5 Boyle’s law and Henry’s law.
inversely proportional to the pressure. Atmospheric pressure increases with depth, increasing by 1 atmosphere for each 10 m of depth in water. During diving this increasing pressure compresses the gas within the human body, including the lungs, ears, sinuses and bowels. During ascent this gas expands and can cause barotrauma
liquid is proportional to the partial pressure of the gas. Nitrogen is not metabolised by the body and increasingly dissolves into the blood on descent. The reverse occurs on ascent, which if ascending too quickly can cause bubbles to form, resulting in decompression sickness.
Fu r th e r i n fo r ma t i on  259
https://t.me/medicina_free
Arterial gas embolism
Expanding gases during ascent from diving, from depths as little as 1 metre, can rupture the alveolar capillary membrane (barotrauma), intro­ducing alveolar gas into the arterial circulation. The brain is the most commonly affected organ. Small venous gas emboli are common with diving and usually are of no clinical consequence due to pulmonary cap­illary ltering. A patent foramen ovale is seen in around a quarter of the population which can result in these emboli transferring to the arterial circulation, causing neurological sequelae. Overall, the risk of arterial gas embolism is rare, representing only around 4% of documented decom­pression illnesses. Risks include rapid ascents, breath holding and pre-existing pulmonary disease. If there is rapid onset of neurological signs, including seizures or a reduced consciousness following ascent, arterial gas embolism should be suspected.
Management
Any obtunded patient should have appropriate rst aid. Denitive treat­ment for decompression illness is providing 100% oxygen to wash out gas from the tissues to the lungs and remove bubbles. This should be instigated for all patients regardless of their oxygen saturations.
Chamber recompression is the gold standard therapy and should be performed as soon as possible causing a theoretical crushing of bubbles (as per Boyle’s law) and providing improved oxygenation to damaged tis­sues. Extraction to a recompression chamber may require aeromedical retrieval and helicopters at low altitude (less than 300 m) or those with cabins pressurised to 1 atmosphere are recommended. In-water recom­pression is controversial and is recommended only for divers, including the patient, with specic training in decompression procedures underwa­ter. Previous recommendations of a head-down position to stop cranial spread of bubbles is no longer recommended due to the increased risk of cerebral oedema; patients should be kept horizontal. One litre of intra­venous uid should be given to correct the intravascular uid loss from endothelial bubble injury and dehydration associated with immersion. Analgesia should be avoided; non-steroidal anti-inammatory drugs can result in haemorrhage whilst opiates raise the risk of oxygen toxicity. The Divers Alert Network can be contacted for international advice and support.
Immersion pulmonary oedema
Immersion pulmonary oedema can affect surface swimmers as well as divers and is believed to be a leading cause of death during the swim stage of triathlons, previously felt to be due to drowning. Immersion results in exposure to hydrostatic pressure which collapses veins and redistributes blood to the thorax, causing increased preload, cardiac contractility and stroke volume. Rising pulmonary alveolar capillary pressure results in a uid shift into the lung interstitium initially, followed
by the alveoli. This is normally balanced by the release of natriuretic peptides (ANP and BNP) causing a natriuresis and diuresis, however in immersion pulmonary oedema this compensation is overwhelmed. Risk factors include overhydration, overexertion, heart disease, hyper­tension and cold water, all resulting in raised ventricular lling pressures. Breathing into a snorkel or scuba equipment can result in higher neg­ative pressures in the alveoli with a subsequent greater uid transu­dation into them (the opposite of positive pressure ventilation used to treat pulmonary oedema). Symptoms range from shortness of breath to haemoptysis and frothy sputum, generally occurring within 10 min­utes of starting swimming, and of variable onset with diving. Treatment involves extraction from the water to remove the hydrostatic pressure, which in turn decreases ventricular lling pressures. Patients should be kept warm to prevent vasocontriction, sat upright and given 100% oxygen. In-hospital management involves a combination of vasodilators (nitrates), diuretics and positive-pressure ventilation (CPAP). Recurrence rates are around 30%.
Shallow-water blackout
This condition refers to the loss of consciousness underwater when hyperventilation is followed by breath holding. It generally occurs in water less than 5 m in depth and can affect even experienced swim­mers. Hyperventilation (as rapid shallow breaths before diving) preceding a breath hold lowers the arterial CO2 and delays the hypercarbic stim­ulus to breathe, which may not occur before hypoxaemia and uncon­sciousness develop. Unconsciousness usually occurs on ascent as the hydrostatic pressure decreases, reducing the thoracic shunting of blood and gas exchange, coupled with a decreasing partial pressure of oxygen (Boyle’s law) and resulting in a signicant hypoxaemia.
Further information
Books
Edmonds C, Bennett M, Lippmann J, Mitchell S. Diving and subaquatic medicine,
5th edn. Boca Raton: CRC Press; 2016. An excellent review of subaquatic medicine.
Websites
rgs.org Royal Geographical Society. Multiple downloadable expedition guidance
documents for a range of environments.
christopherimray.co.uk/highaltitudemedicine Extensive publications on high
altitude medicine and cold injury by Professor Chris Imray.
altitude.org A website written by doctors with expertise and experience of
expedition and altitude medicine.
scholar.google.co.uk/citations?user=ZJRl2HEAAAAJ&hl=en Lists publications
by Professor Mike Tipton of the Extreme Environments Laboratory, University of Portsmouth, on cold water immersion, thermoregulation and environmental physiology.
12
This page intentionally left blank
https://t.me/medicina_free
Multiple Choice Questions
https://t.me/medicina_free
12.1 You are part of a search and rescue team looking for a trapped skier, following an avalanche 20 minutes prior. On nding the patient you are instructed by the team leader to move them very carefully, to not induce a cardiac arrhythmia. Below what core temperature can ventricular brillation be induced from excessive movement?
A. 36°C B. 32°C C. 35°C D. 30°C E. 33°C
Answer: D.
Answer: D.
There are a number of adaptations to resuscitation algorithms for hypothermic patients in cardiac arrest. Assessment for signs of life should be extended to 1 minute. Ventricular brillation and ventricular tachycardia can be debrillated, however if after three shocks there is no response, additional shocks should be delayed until core temper­ature is greater than 30°C. Stacked shocks are not recommended. Withhold adjunctive medications (adrenaline, amiodarone, etc.) if the patient is below 30°C, and double the interval time between doses between 30°C and 35°C.
Markers of futility include: obvious lethal injury, prolonged asphyxia (mouthful of snow etc.), incompressible thorax (distinct from a stiff chest which is common), frozen abdomen, or potassium > 12 mmol/L.
12.4 With regards to freezing cold injury (frostbite), which of the
following statements around management is correct?
As the core temperature falls there is a reduction in cardiac output with initial maintenance of stroke volume. At around 28°C the heart rate is reduced by 50%. Initial conduction abnormalities include a sinus brad­ycardia, progressing to slow atrial brillation (AF) and then to ventricular brillation (VF). VF may be induced below 30°C with excessive stimula­tion/movement, which is why handling of hypothermic patients needs to be performed with great care.
12.2 You are working as a medic for a 100-mile ultramarathon,
environmental conditions are wet (moderate rain), with a temperature of 8°C. You are asked to see a competitor who has come into the medical tent after 12 hours of running. The competitor is drowsy, confused and is not shivering. Blood sugar is normal. You do not have access to a rectal thermometer. Using the Swiss Staging System, quantify the possible degree of hypothermia for this patient.
A. < 24°C B. 28–31°C C. 24–27°C D. 32–35°C E. 35–36°C
Answer: B.
Traditionally, hypothermia is categorised as mild (32–35°C), moderate (28–32°C) and severe (< 28°C), however newer staging systems, such as the Swiss Staging System, adopted by some ambulance services, dene the level of hypothermia based on symptoms (see Fig. 12.3). This has been shown to overestimate the degree of hypothermia in around 20% of cases but remains a helpful classication when an accurate core temperature cannot be obtained.
12.3 Which of the following statements is true for adaptations to
resuscitation algorithms for hypothermic patients in cardiac arrest?
A. The affected area should always be rewarmed immediately in
the pre-hospital environment B. Early amputation is the gold standard therapy C. Rubbing of the area with direct application of heat pads to
thaw the affected region is recommended D. Analgesia is not required, freezing injuries are not painful E. Aspirin 75–300 mg and ibuprofen 800 mg are recommended
Answer: E.
If concerned about the possibility of cold injury, immediate pre-hos­pital treatment is to try to shelter from the environment, consume warm drinks, remove shoes, wet clothing and jewellery and re-dress in warm, dry clothing. If there is absolutely no risk of re-freezing then warming the area can be achieved by placing the area into a companion’s armpit or groin. Aspirin 75–300 mg and ibuprofen 800 mg are recommended. Do not rub the area and do not place heat sources directly onto the area. Evacuation for formal medical review should be obtained. Warmed areas need to be made non-load-bearing and therefore prior thought about extraction needs to be considered. Aloe vera gel has anti-prostaglandin effects and can be applied before application of a non-adherent dressing, splinting and elevation of the affected region.
Denitive warming involves placing the affected area into circulat­ing water between 37°C and 42°C with small amounts of antiseptic for around an hour, avoiding contact with the sides of the container. Additional treatment involves uid replacement with warmed uids (due to cold diuresis), strong analgesia and blister care. Blisters may present as clear, cloudy or haemorrhagic. Blister management remains contro­versial, with current evidence recommending débridement of all blisters in hospital (likely under a general anaesthetic), to improve wound heal­ing. There is no evidence for prophylactic antibiotics and tetanus should be given following local protocols; frostbite wounds are not considered tetanus-prone.
12.5 The most readily modiable physiological risk factor for the
development of heat illness is:
A. Withhold all shocks – chance of shockable rhythm < 5% B. Signs of life should be checked for 30 seconds rather than 10
seconds
C. Do not warm hypothermic patients in cardiac arrest – the
hypothermia is neuroprotective
D. Withhold medications (adrenaline, amiodarone etc.) until core
temperature > 30°C and double the interval time between doses between core temperatures of 30°C and 35°C
E. A potassium level of 7 mmol/L is diagnostic of resuscitation
futility
A. Obesity B. Hydration C. Acclimatisation D. Use of beta-blockers E. Aerobic tness
Answer: B.
The 2019 Wilderness Medical Society heat illness guidelines identify hydration as the ‘most readily modiable physiologic risk factor’. Fluid
ingestion is also identied as the most effective approach to mitigate the
https://t.me/medicina_free
rise in core temperature amongst athletes. Military guidelines recommend a 0.25 L/hr – 1.25 L/hr hydration strategy that varies for work rates (low/ medium/high/very high) at a given Wet Bulb Globe Temperature (WBGT).
12.6 The denition of heat stroke is:
A. Mild swelling to the limbs during the rst few days of heat
exposure due to increased plasma volume B. Neurological impairment with core body temperature 40°C C. A transient loss of consciousness in the context of heat expo-
sure with a relatively rapid return to normal function and baseline D. It is an inability to continue an activity due to heat stress E. Body spasms related to sodium loss
Answer: B.
Heat-related illness denes a spectrum of pathology from benign heat oedema to lethal heat stroke. The denition of heat stroke is: neurological impairment with core body temperature 40°C (rectal temperature is gold standard in a pre-hospital environment). Symptoms can involve a coarse muscle tremor, confusion, aggression and loss of consciousness. Sweating may be absent due to dehydration and failure of thermoregu­latory mechanisms.
12.7 You are working on an expedition in the Costa Rican jungle. The
expedition leader asks you theoretically what the best cooling strategy is for patients with heat stroke. In your current location you only have access to cold water. You suggest:
A. Removing the patient into the shade B. Calling for a helicopter to use the downwash from the blades C. Forcing the patient to drink cold water D. Spraying the patient with cool water and using a combination
of evaporative and convective heat loss
E. Ice water immersion.
Answer: D.
A number of cooling strategies exist and their implementation will depend on what is feasible within each particular environment. Two meta-analyses have concluded that ice water immersion is the most effective treatment strategy, with cooling rates of 0.20°C–-0.35°C/min for iced water and 0.11°C/min for wet towels. Immersion is unlikely to be feasible in the wilderness environment and in many hospitals, with further consideration for the dangers of potentially immersing a patient with a reduced conscious level.
The placement of ice/cold packs in the axillae, groin and neck has been recommended as an easy method to use in the eld, but when compared with evaporative cooling in ve healthy subjects, cooling times were longest when the ice packs were used alone and shortest when both methods were used simultaneously. Evaporative cooling involves the removal of clothing, spraying tepid or cool water over the patient, and facilitating evaporation and convection with the use of a fan.
12.8 You are working on an expedition on Mont Blanc and are
asked to see a patient who at 3500 m has developed a wet cough with frothy sputum. The patient is tachycardic with a high respiratory rate and you hear bibasal crepitations in both lungs. The patient insists they have mild acute mountain sickness, which they have had previously, and wants to continue to summit. They have taken no prophylactic medications. What is the most appropriate plan?
A. The patient likely has high altitude pulmonary oedema and
should immediately descend by at least 1000 m alongside giving high-ow oxygen
B. The patient is most likely correct and has mild acute mountain
sickness and should be allowed to summit
C. The patient has high altitude cerebral oedema and should
be given 8 mg of dexamethasone and then start to descend
D. The patient has no evidence of high altitude illness, and the
ndings are consistent with normal physiological changes at altitude. No action is required
E. The patient has severe acute mountain sickness and should
remain at their current altitude for 2–3 days
Answer: A.
HAPE is a life-threatening condition that usually occurs in the rst 4 days after ascent above 2500 m and is the leading cause of mortality from high altitude illness. Hypoxic pulmonary vasoconstriction causes alveolar capil­lary stress failure and subsequent pulmonary hypertension. This results in capillary uid leak which is exacerbated by exercise and compounded by impaired epithelial sodium transport, normally essential for uid reabsorp­tion. Initial symptoms include a dry cough, exertional dyspnoea and extreme fatigue. Later, the cough becomes wet with haemoptysis and orthopnoea. Tachycardia and tachypnoea occur at rest and crepitations may often be heard in both lung elds. Fever may also be present. There may be profound hypoxaemia and radiological evidence of diffuse alveolar oedema. HAPE may occur without the preceding signs of AMS, although around 50% of patients with HAPE have concurrent AMS and 14% have HACE.
Treatment is directed at reversal of hypoxia, with immediate descent (by a minimum of 1000 m) and oxygen administration targeting satura­tions > 90%. A portable hyperbaric chamber should be used if descent is delayed. Prophylactically, nifedipine (60 mg modied release divided into 2–3 doses) should be given to reduce pulmonary arterial pressure, ideally 1 day preceding ascent and continued for a further 5 days.
12.9 You are working in an Emergency Department and are asked
to review a 17-year-old male patient who 1-hour prior aspirated some water whilst swimming in the sea and was rescued by members of the public who described initial panicking and respiratory impairment. The patient appears well, with normal observations. The most appropriate plan is:
A. The patient is suitable for discharge with no evidence of
ongoing respiratory distress B. The patient is suitable for discharge following a normal chest X-ray C. The patient is suitable for discharge following 6–8 hours’
observation if his observations remain normal, with a normal
chest X-ray ± normal arterial blood gas D. The patient should be admitted for 72 hours to observe for
delayed acute respiratory distress syndrome (ARDS) E. The patient does not need to be seen in an Emergency
Department and should be discharged home without review
Answer: C.
Drowning is dened as ‘the process of experiencing respiratory impair­ment from submersion/immersion in liquid’. Asymptomatic patients, with no respiratory compromise, a normal chest X-ray and normal arterial blood gas can be discharged home after 6–8 hours’ observation.
12.10 You are on holiday on a beach and see a 50-year-old female
swimmer in difculty. She is dragged from the water by a rst aider on scene and is currently lying on her back in the shallow water with small waves breaking over her. She is alert but is coughing frequently, with a fast respiratory rate. The rst aider does not wish to move the patient due to the risk of a cervical spine injury. The most appropriate plan is:
A. Assist the rst aider by applying cervical spine immobilisa-
tion and wait for an ambulance to arrive with a scoop
B. Drag the patient up the beach out of the water to prevent
https://t.me/medicina_free
further aspiration or development of hypothermia
C. Acknowledge the rst aider’s concern, but reassure that
the risks are low (0.5%) for a cervical injury and it would be safest to ask the patient to move with help up the beach
D. Do nothing, the patient is clearly alert and breathing and no
further intervention is required
E. Administer 5 rescue breaths, followed by raising the patient’s
body above their head to allow for postural drainage of water from the lungs
Answer: C.
The safest option is to remove the patient from the water due to the
ongoing risk of further aspiration and ongoing cooling with subsequent
hypothermia. Risk of cervical spine injury is low (0.5%). Asking the
patient if they are able to move up the beach with support is the most
appropriate initial step. Postural drainage techniques are not recom-
mended, with no evidence of benet.
DH Dockrell
https://t.me/medicina_free
S Sundar
BJ Angus
13
Infectious disease
Clinical examination of patients with infectious disease 262
Presenting problems in infectious diseases 264
Fever 264 Positive blood culture 270 Sepsis 271 Acute diarrhoea and vomiting 272 Infections acquired in the tropics 274 Infections in adolescence 278 Infections in pregnancy 279
Viral infections 279
Systemic viral infections with exanthem 279 Systemic viral infections without exanthem 283 Viral infections of the skin 290 Gastrointestinal viral infections 292 Respiratory viral infections 292 Viral infections with neurological involvement 298 Viral infections with rheumatological involvement 299
Prion diseases 299
Bacterial infections 299
Bacterial infections of the skin, soft tissues and bones 299 Systemic bacterial infections 303 Gastrointestinal bacterial infections 309 Respiratory bacterial infections 312 Bacterial infections with neurological involvement 314 Mycobacterial infections 314 Rickettsial and related intracellular bacterial infections 316 Chlamydial infections 319
Protozoal infections 319
Systemic protozoal infections 319 Leishmaniasis 326 Gastrointestinal protozoal infections 330
Infections caused by helminths 332
Intestinal human nematodes 332 Tissue-dwelling human nematodes 335 Zoonotic nematodes 337 Trematodes (ukes) 338 Cestodes (tapeworms) 340
Ectoparasites 342
Fungal infections 342
Supercial mycoses 343 Subcutaneous mycoses 344 Systemic mycoses 344